Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
„Symplicity Spyral“ inkstų denervacijos sistema:
SPYRAL HTN-ON MED bandomajame tyrime po trejų metų kraujospūdžio sumažinimas naudojant „Symplicity“ kraujospūdžio procedūrą išlikdavo dieną ir naktį, įskaitant pavojingus laikotarpius vėlai naktį ir anksti ryte, kurie dažniausiai siejami su padidėjusia insulto ir širdies bei kraujagyslių būklių rizika.3
Peržiūrėkite trumpą animaciją, kurioje paaiškinamas RD inkstų denervacijos naudojant „Symplicity Spyral“ sistemą veikimo mechanizmas.
In typical uncontrolled hypertension patients.
ANCOVA adjusted; secondary efficacy analysis.
RDN arm reduction from baseline.
Includes Symplicity Spyral™ and Flex™ catheters.
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet. 2020;395:1444–1451.
Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. The Lancet. 2018;391(10137):2346–2355.
Mahfoud F, Mancia G, Schmieder R, et al. Three-year safety and efficacy in the Global Symplicity Registry: Impact of antihypertensive medication burden on blood pressure reduction. Presented at PCR e-course 2020.
Mahfoud F, Kandzari DE, Kario K, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. The Lancet. 2022;399:1401–1410.
Coates P, Tunev S, Trudel J, et al. Time, temperature, power, and impedance considerations for radiofrequency catheter renal denervation. Cardiovascular Revascularization Medicine. 2022.
Medtronic Data on File.
Medtronic Symplicity Spyral™ Instructions for Use.